INTERNATIONAL PATENT: KEYMED BIOSCIENCES (CHENGDU) CO., LTD., SHANGHAI MIRACOGEN INC. FILES APPLICATION FOR "CANCER TREATMENT WITH ANTI-CLAUDIN 18.2 ADC"

GENEVA, May 4 -- KEYMED BIOSCIENCES (CHENGDU) CO., LTD. (Building D2, No.18 Bio-Town Middle Road, Chengdu Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610219), SHANGHAI MIRACOGEN INC. (Suite 4E, Building 3, No. 1238 Zhangjiang RdPudong New Area, Shanghai 201203) filed a patent application (PCT/CN2023/127269) for "CANCER TREATMENT WITH ANTI-CLAUDIN 18.2 ADC" on Oct 27, 2023. With publication no. WO/2025/086270, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Bo (c/o Keymed Biosciences (Chengdu) C...